AC
Arch Biopartners Inc.
ACHFF · OTC
$0.63 +2.17% (+$0.01)
1M -18.62%
Market Cap $60.5M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.4
36.9% downside
Current Price
$0.63
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACHFF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 209.83%
Asset turnover 0.00x
ROA 4,909.48%
Debt
0 /100
High Current ratio 0.01x
Int. coverage -11.00x
Debt/Equity N/A
Stability
4 /100
Unstable Beta 1.76x
Profitable years 0
Rev. volatility 102.86%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACHFF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Gabriel Muruve
Employees
6
Headquarters
Toronto
Upcoming events
02 FEB
Earnings
Upcoming earnings report